Unlocking the Future of Dialysis


About Advent Access

Advent Access is a medical technology startup focused on end-stage renal disease management. A Stanford StartX company and spin-off from A*STAR, Advent’s mission is to pioneer innovations to significantly reduce dialysis cost and improve quality of life for kidney failure patients. The company’s first product is the av-Guardian™ - an award-winning implant technology that aims to improve vascular access reliability, enable less-painful cannulation and, in the long run, potentially reduce vascular access related hospitalizations. The av-Guardian™ forms a key component of Advent Access’ dialysis-machine agnostic platform to empower patients to perform guided hemodialysis consistently and safely across dialysis care environments. 



Advent Access today announced receipt of the CE Mark certificate for its award-winning av-Guardian™ vascular access system. The certificate indicates av-Guardian™’s conformity with health, safety, and environmental protection standards set by the European Union for a device to be distributed into the European Economic Area.


Read more

Advent Access, an end-stage renal disease management medical technology company who designed and developed the av-Guardian™ Vascular Access System, is proud to share it has received ISO 13485:2016 certification for its Quality Management System from DEKRA Certification B.V. 

ISO 13485 is an internationally recognized standard specific to the medical device industry for a quality management syst...

Founder Ruey Feng PEH spoke with CNBC about our invention, av-Guardian,

as a guardian "guide door" to the arteriovenous  fistula (AVF) that enables reliable access to AVF. 


Link to video >

Please reload


Executive Committee

lu yoh-chie
peh ruey feng
abel ang

Clinical Advisors


Clinical Advisor

Picture1 copy.png

Patient Engagement Advisor


Safety &
Performance Study

Study name  

Non randomised safety and performance evaluation of the av-Guardian Vascular Access System for hemodialysis patients

Study site  

Multi-center Singapore study at Singapore General Hospital, National University Hospital, supported by National Kidney Foundation, Singapore 

Self-Cannulation &
Self-Hemodialysis Study

Study name  
Non randomised safety and performance evaluation of the av-Guardian Vascular Access System for deep AVF & for use of self-cannulating patients.

Study site  
Waikato Hospital, New Zealand


©2019 By Advent Access Pte. Ltd. All Rights Reserved.